Recent Updates
Recently added Catalysts
HRTX

Legal Disclaimer September 2011 2011. A.P. Pharma, Inc. All rights reserved. 2 This presentation contains forward looking statements as defined by the Private Securities Litigation Reform Act of 1995. These forward looki

Key Takeaway: CINV Market Dynamics Injectable Drugs for the Number of Package Units Sold by Quarter Q2 06 Q3 06 Q4 06 Q1 07 Q2 07 Q3 07 Q4 07 Q1 08 Q2 08 Q3 08 Q4 08 Q1 09 Q2 09 Q3 09 Q4 09 Q1 10 Q2 10 Q3 10 Q4 10 Q1 11 Q2 11 ALOXI ANZEMET KYTRIL KYTRIL Generic (GRANISETRON) ZOFRAN ZOFRAN

Full Press Release Details

CINV Market Dynamics
Injectable Drugs for the
Number of Package Units Sold by Quarter
Q2 06 Q3 06 Q4 06 Q1 07 Q2 07 Q3 07 Q4 07 Q1 08 Q2 08 Q3 08 Q4 08
Q1 09 Q2 09 Q3 09 Q4 09 Q1 10 Q2 10 Q3 10 Q4 10 Q1 11 Q2 11
ALOXI ANZEMET KYTRIL KYTRIL Generic (GRANISETRON) ZOFRAN ZOFRAN Generic (ONDANSETRON) EMEND
* US Oncology data added starting Q1 09.
Source: Wolters Kluwer
Usage in CINV estimated
Last updated: Sep 20, 2011